A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
Public ClinicalTrials.gov record NCT00240370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Active-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Compared to Pioglitazone in Combination With Metformin in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate if type 2 diabetics who have inadequate glycemic control on metformin alone, have a similar, or not inferior, glycemic response when treated with the combination of muraglitazar and metformin compared to pioglitazone and metformin.
Study identification
- NCT ID
- NCT00240370
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,159 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2003 (Type not available)
- Primary completion
- Mar 2005 (Actual)
- Completion
- Not listed
- Last update posted
- Sep 14, 2010
Started 2003
United States locations
- U.S. sites
- 70
- U.S. states
- 29
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Columbiana | Alabama | — | — |
| Local Institution | Mesa | Arizona | — | — |
| Local Institution | Peoria | Arizona | — | — |
| Local Institution | Carlisle | Arkansas | — | — |
| Local Institution | Jonesboro | Arkansas | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Pine Bluff | Arkansas | — | — |
| Local Institution | Sherwood | Arkansas | — | — |
| Local Institution | Anaheim | California | — | — |
| Local Institution | Artesia | California | — | — |
| Local Institution | Encino | California | — | — |
| Local Institution | Encintas | California | — | — |
| Local Institution | Fresno | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | Northridge | California | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Hamden | Connecticut | — | — |
| Local Institution | Altamonte Springs | Florida | — | — |
| Local Institution | Hollywood | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | New Port Richie | Florida | — | — |
| Local Institution | Saint Cloud | Florida | — | — |
| Local Institution | West Palm Beach | Florida | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Evansville | Indiana | — | — |
| Local Institution | Lafayette | Indiana | — | — |
| Local Institution | New Orleans | Louisiana | — | — |
| Local Institution | Shreveport | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | Gulfport | Mississippi | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Omaha | Nebraska | — | — |
| Local Institution | Endwell | New York | — | — |
| Local Institution | Cary | North Carolina | — | — |
| Local Institution | Charlotte | North Carolina | — | — |
| Local Institution | Raleigh | North Carolina | — | — |
| Local Institution | Rudd | North Carolina | — | — |
| Local Institution | Statesville | North Carolina | — | — |
| Local Institution | Wilmington | North Carolina | — | — |
| Local Institution | Winston-Salem | North Carolina | — | — |
| Local Institution | Bellbrook | Ohio | — | — |
| Local Institution | Maumee | Ohio | — | — |
| Local Institution | Thornville | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Camp Hill | Pennsylvania | — | — |
| Local Institution | Melrose Park | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | West Chester | Pennsylvania | — | — |
| Local Institution | Youngwood | Pennsylvania | — | — |
| Local Institution | East Providence | Rhode Island | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Clinton | South Carolina | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Carrollton | Texas | — | — |
| Local Institution | Corpus Christi | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Midland | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Lebanon | Virginia | — | — |
| Local Institution | Spokane | Washington | — | — |
| Local Institution | Tacoma | Washington | — | — |
| Local Institution | Bluefield | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00240370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2010 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00240370 live on ClinicalTrials.gov.